Sinovac secures $500 million Funding for COVID-19 vaccine development
BEIJING: Sinovac Life Sciences Co., Ltd. has secured approximately US$500 million in funding for further development, capacity expansion and manufacturing of the CoronaVac, its COVID-19 vaccine candidate, as well as conduct other development and operational activities, a news release said….